Insider Trading & Ownership - KIDRON NADAV

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KIDRON NADAV
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-03-16
Purchase
2023-03-16
5:10 pm
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
26,000$2.039$53,0141,179,098
(Indirect
Direct)
View
2023-03-14
Purchase
2023-03-15
5:25 pm
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
100,000$2.01$201,0001,153,098
(Indirect
Direct)
View
2021-08-09
Sale(A)
2021-12-07
4:30 pm
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
10% Owner
220,000$20.11$4,423,144738,209
(Direct)
View
2021-08-09
Sale
2021-08-11
5:15 pm
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
10% Owner
220,000$20.11$4,423,144648,573
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-07
Option Award
2024-11-08
4:30 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
45,000$01,952,098
(Direct)
View
2024-01-04
Option Award
2024-01-08
4:41 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
329,000$01,907,098
(Direct)
View
2023-05-26
Option Award
2023-05-31
5:10 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
120,000$01,578,098
(Direct)
View
2023-04-17
Option Award
2023-04-20
06:00 am
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
279,000$01,458,098
(Direct)
View
2022-10-27
Gift
2022-10-28
9:30 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
25,000$01,053,098
(Direct)
View
2022-07-28
Option Award
2022-08-01
8:00 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
160,000$01,078,098
(Direct)
View
2022-08-01
Tax Withholding
2022-08-01
8:00 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
12,631$8.361,078,098
(Direct)
View
2022-01-03
Option Award(A)
2022-01-11
8:30 pm
N/A
2032-01-03
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
320,000$01,037,729
(Direct)
View
2022-01-03
Tax Withholding(A)
2022-01-11
8:30 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
48,752$13.891,037,729
(Direct)
View
2022-01-03
Option Award
2022-01-05
8:41 pm
N/A
2032-01-03
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
320,000$01,057,729
(Direct)
View
2022-01-03
Tax Withholding
2022-01-05
8:41 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
48,752$13.891,057,729
(Direct)
View
2021-12-28
Tax Withholding
2021-12-30
9:31 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
31,728$12.98766,481
(Direct)
View
2021-12-30
Gift
2021-12-30
9:31 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
20,000$0766,481
(Direct)
View
2021-12-03
Gift
2021-12-07
5:15 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
20,000$0818,209
(Direct)
View
2021-08-31
Option Award(A)
2021-12-07
4:30 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
100,000$0838,209
(Direct)
View
2021-08-31
Option Award
2021-09-02
4:43 pm
N/A
N/A
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
100,000$0748,573
(Direct)
View
2021-02-03
Option Award
2021-02-08
5:30 pm
N/A
2031-02-03
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
10% Owner
150,000$0150,000
(Direct)
View
2020-01-08
Option Award
2020-01-14
4:06 pm
N/A
2030-01-08
ORAMED PHARMACEUTICALS INC.ORMPKIDRON NADAV
President and CEO
10% Owner
190,000$0190,000
(Direct)
View
(A) Indicate amendment filing.